The Genome Sequencing Center at Washington University School of Medicine increased its sequencing capacity with the acquisition of five new Genome Sequencer FLX Systems from Roche Diagnostics. The center will be able to support a wide variety of projects, including transcriptome analysis of individual tumors and human microbiome studies.
The Human Genome Sequencing Center at Baylor College of Medicine has acquired seven additional Genome Sequencer FLX Systems from 454 Life Sciences, a Roche company. The center will use these instruments to analyze genetic changes in diseases such as cancer, heart disease, and asthma.
A population-based surveillance study found that treatment with Tamiflu (oseltamivir) significantly reduced mortality from seasonal influenza in severely ill adults. The study, conducted in Ontario, Canada, showed a 71% reduction in death from influenza among treated patients.
A new computational approach helps researchers understand the relationship between trait differences and variations in the mouse genome, moving closer to understanding human genetic differences. The method also has potential to uncover currently unknown genetic factors contributing to various diseases.